Catalyst: A Biopharmaceutical Company Focused on Rare Diseases

Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.

FDA Approves Firdapse for Treatment of Rare Autoimmune Disorder

Continuing Innovation for Rare Conditions Under the Orphan Drug

Catalyst Pharmaceuticals, Inc. on LinkedIn: Catalyst

Top 32 Similar websites like fdatracker.com and alternatives

Catalyst Achieves Positive Results From Second Phase 3 Trial

Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals - Axxiem Web Solutions

Catalyst Pharmaceuticals Posts Positive Trial Data for Rare

Zacks Research Weighs in on Catalyst Pharmaceuticals, Inc.'s Q1

UCL Research Catalyst Awards: tackling rare diseases in Brazil

Catalyst Pharmaceuticals hit by FDA extra studies request for

Catalyst Pharmaceuticals, Inc. on LinkedIn: February 28, Closing Bell